Honey Rose, Tañola .

HRN: 26-20-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2025
CEFUROXIME 1.5GM (VIAL)
01/03/2025
01/09/2025
ORAL
500mg
2 Times A Day
Urinary Tract Infection
Waiting Final Action 
01/03/2025
CEFUROXIME 500MG (TAB)
01/03/2025
01/09/2025
ORAL
500mg
2 Times A Day
Urinary Tract Infection
Waiting Final Action 
01/03/2025
CEFUROXIME 750MG (VIAL)
01/03/2025
01/09/2025
PO
500mg
Q8
UTI
Waiting Final Action 
01/03/2025
CEFTRIAXONE 1G (VIAL)
01/03/2025
01/09/2025
IV
2g
OD
Uti In Pregnancy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: